ALAPROCLATE HYDROCHLORIDE

Details

Stereochemistry	RACEMIC
Molecular Formula	C13H18ClNO2.ClH
Molecular Weight	292.201
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

Cl.CC(N)C(=O)OC(C)(C)CC1=CC=C(Cl)C=C1

InChI

InChIKey=OPAKSOWFKIUFNP-UHFFFAOYSA-N

InChI=1S/C13H18ClNO2.ClH/c1-9(15)12(16)17-13(2,3)8-10-4-6-11(14)7-5-10;/h4-7,9H,8,15H2,1-3H3;1H

HIDE SMILES / InChI

Molecular Formula	C13H18ClNO2
Molecular Weight	255.741
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6205120 | https://www.ncbi.nlm.nih.gov/pubmed/7936117 | https://www.ncbi.nlm.nih.gov/pubmed/3883697 | https://www.ncbi.nlm.nih.gov/pubmed/6433393/

Alaproclate is a selective 5-HT uptake inhibitor. Alaproclate enantiomers block potassium and NMDA receptor currents in a stereoselective manner. Alaproclate was practically devoid of action on a number of receptors as examined in binding studies in vitro: 5-HT, histamine-H1, alpha 1, -alpha 2-adrenergic and dopamine D2 receptors. Alaproclate was investigated in trials for the treatment of depression and dementia.

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Glutamate NMDA receptor 47 Target ID: CHEMBL1907608 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7996440 \| https://www.ncbi.nlm.nih.gov/pubmed/12851738	Antagonist 2849		0.3 µM [IC50]
serotonin uptake 20 Target ID: GO:0051610 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7996440	Inhibitor 8504

PubMed

Title	Date	PubMed
Effects of serotonergic agents on survival and hemolymph composition of the larval mosquito Aedes aegypti (Diptera: Culicidae, L.) in vivo: does serotonin regulate hemolymph acid-base homeostasis?	2009-11	19880735
Chronic fluoxetine treatment increases daytime melatonin synthesis in the rodent.	2009	22291481
Alpha-2 adrenergic-induced changes in rectal temperature in adult and 13-day old rats following acute and repeated desipramine administration.	2008-10-02	18831759
Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram.	2008-08-19	18665165
Serotonin reuptake inhibitors do not prevent 5,7-dihydroxytryptamine-induced depletion of serotonin in rat brain.	2004-05-08	15064132
Inhibitory actions of serotonin on glutamate release in dorsal medulla suppress systemic arterial pressure of cats.	2004-01-23	14729238
Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats.	2003-11	12851738
Open space swimming test to index antidepressant activity.	2003-06-15	12788500
Affinity and specificity of N-methyl- D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats.	2003-02	12459931
Endogenous activation of serotonin-2A receptors is required for respiratory rhythm generation in vitro.	2002-12-15	12486201
Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys.	2002-03	11861788
Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys.	2002-01	11862343

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 22:52:11 GMT 2025` Edited by `admin` on `Mon Mar 31 22:52:11 GMT 2025`
Record UNII	NIH506S9US
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ALAPROCLATE HYDROCHLORIDE

Common Name

English

DL-ALANINE, 2-(4-CHLOROPHENYL)-1,1-DIMETHYLETHYL ESTER, HYDROCHLORIDE

Preferred Name

English

ALANINE, 2-(4-CHLOROPHENYL)-1,1-DIMETHYLETHYL ESTER, HYDROCHLORIDE (1:1)

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID80976158